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Transposon insertion provides a method for near-random mutation of bacterial genomes,
and has been utilized extensively for the study of bacterial pathogenesis and biology.
This approach is particularly useful for organisms that are relatively refractory to
genetic manipulation, including Lyme disease Borrelia. In this review, progress to date
in the application of transposon mutagenesis to the study of Borrelia burgdorferi is
reported. An effective Himar1-based transposon vector has been developed and used to
acquire a sequence-defined library of nearly 4500 mutants in the infectious, moderately
transformable B. burgdorferi B31 derivative 5A18NP1. Analysis of these transposon
mutants using signature-tagged mutagenesis (STM) and Tn-seq approaches has begun to
yield valuable information regarding the genes important in the pathogenesis and biology
of this organism.
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Lyme disease is a tick-transmitted, multi-stage bacterial infec-
tion caused by several species of the genus Borrelia, including
the primary agents B. burgdorferi, B. garinii, and B. afzelii (Steere
et al., 2004). These spirochetes are maintained in nature through
a cycle involving transmission between small mammals and ticks
of the Ixodes ricinus group. Large mammals such as deer are
also required for the feeding of the adult ticks and hence egg
production. Humans are accidental hosts that are infected by
the bite of Borrelia-infested ticks, usually of the nymphal stage.
Most infected humans develop mild fever, malaise, and a local-
ized skin lesion called erythema migrans days to weeks after the
tick bite, followed by dissemination of propagating organisms
through the blood and lymphatics to other tissues. Later manifes-
tations may include neurologic effects, joint involvement, cardiac
block, and skin lesions called acrodermatitis chronica atroph-
icans. If untreated, infection can last for months to years; in
mouse studies, organisms can be reisolated from almost any tis-
sue throughout the lifetime of the animal. Despite this pattern
of pathogenesis, B. burgdorferi produces no known toxins. Lyme
disease Borrelia thus appear to represent non-toxigenic, invasive,
persistent pathogens that cause disease through the induction
of host inflammatory reactions, similar to Treponema pallidum
(syphilis) and Mycobacterium tuberculosis (Norris et al., 2010).
Since its initial discovery and culture in 1981, B. burgdorferi has
been the subject of intensive study in an attempt to better under-
stand the biology of this organism and thereby identify properties
useful in the diagnosis, treatment, or prevention of Lyme dis-
ease. This work has resulted in tremendous progress (Rosa et al.,
2005; Samuels and Radolf, 2010), particularly in terms of under-
standing the spirochete’s molecular biology and the massive gene
regulation that accompanies the transition between the disparate
mammalian and tick host environments. Despite these advances,
several barriers (Table 1) have hampered the ability to fulfill
molecular Koch’s postulates regarding the role of borrelial genes
in biological processes and pathogenesis. While some of these
barriers have been at least partially overcome, transformation
of low-passage, infectious B. burgdorferi remains a challenge.
Thus, site-directed mutagenesis of a particular gene may require
3–6 person-months for the transformation process, outgrowth
of transformants, screening for mutants with appropriate inser-
tions, and plasmid analysis. As a result, fewer than 100 of the 1739
open reading frames (ORFs) in infectious B. burgdorferi have been
subjected to site-directed mutagenesis despite intensive efforts by
several laboratories.
TRANSPOSON MUTAGENESIS OF B. BURGDORFERI
Transposon mutagenesis is a powerful means of producing ran-
domized gene mutations in bacterial genomes (Beaurepaire and
Chaconas, 2007). In 2004, Stewart et al. (2004) reported the
development of a Himar1-based transposon suicide vector called
pMarGent for use in Borrelia organisms. Himar1 is a transpo-
son of the mariner family that was originally isolated from the
blowfly,Drosophila mauritiana. Lampe et al. (1999) selected point
mutants of the Himar1 transposase (included so-called C9 and
A7 derivatives) that exhibited increased transposition rates; the
C9 variant was used in pMarGent. A modified version of pMar-
Gent called pGKT (Figure 1) was later developed to include a
second selectable marker (KanR) in the non-transposed “back-
bone” in addition to the gentamycin resistance gene present in
the transposable element (Stewart and Rosa, 2008). This mod-
ification greatly increases the stability of the vector in E. coli
and facilitates additional alterations (such as the addition of
signature tags). In both pMarGent and pGKT, the transpos-
able element consists of the B. burgdorferi constitutive promoter
flgBP coupled with the gentamicin resistance cassette aacC1 and
the ColE1 origin of replication flanked by two Himar1 inverted
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Table 1 | Challenges to genetic manipulation of Borrelia species.
Barrier Solution(s)
Fragility of organisms Specialized methods for preparation of Borrelia
for electroporation (Samuels, 1995)
Slow growth rate;
inefficient isolation of
mutants
Utilization of either plating or limiting dilution
approaches
Plasmid loss during
in vitro culture
Minimization of in vitro passages (Barbour,
1988)
Careful monitoring of plasmid content
Use of shuttle vectors to replace
virulence-associated plasmid-encoded genes
(e.g., pncA)
Restriction-
modification (R-M)
systems
Disruption of R-M genes
Use of strains lacking plasmids (lp25, lp56) that
encode R-M systems
DNA methylation prior to transformation
FIGURE 1 | Diagram of the transposon vector pGKT-STM1, modified
from the Borrelia-enhanced transposon deliver suicide vector pGKT of
Stewart et al. (Stewart and Rosa, 2008). Features of pGKT include the
use of B. burgdorferi flgB and flaA promoters to increase the efficiency of
expression of the Himar1 c9 transposase and the gentamicin and
kanamycin antibiotic resistance markers. The transposable element is
flanked by the inverted tandem repeats ITR-1 and ITR-2, and contains the
aacC1 gentamicin resistance cassette and the ColE1 origin of replication (to
permit plasmid replication in E. coli and transposon insertion site rescue)
(Stewart et al., 2004). The modification in pGKT-STM1 and other STM
derivatives is the addition of a unique 7-bp signature tag close to ITR2.
tandem repeat sequences (Figure 1). The non-transposed region
of pGKT includes flgBP::C9 transposase gene and the B. burgdor-
feri flaB promoter with the aph kanamycin resistance cassette.
mariner-based transposons insert at any 5′-TA-3′ sequence with
no apparent sequence bias, and result in duplication of the TA
sequence at the other end of the transposon. Stewart et al. (2004)
demonstrated the apparent random insertion of the pMarGent
transposable element in both the chromosome and plasmids with
high transformation efficiency (>3 × 10−5) in the non-infectious
B. burgdorferi clones B31-AchbC72 and A3-89. However, these
strains lack both lp25 and lp56, which contain the restriction-
modification genes bbe02 and bbq67 (Lawrenz et al., 2002); lp25
also contains the pncA nicotinamidase gene that is required for
mammalian and tick infection (Purser et al., 2003; Deneke and
Chaconas, 2008). Attempts to transform the low-passage, infec-
tious B. burgdorferi A3 and N40 strains (which contain lp25) with
pMarGent were unsuccessful (Stewart et al., 2004).
In 2004, Kawabata et al. (2004) introduced the infectious,
transformable B. burgdorferi strains 5A4NP1 and 5A18NP1. Both
strains have a partial deletion and insertion of an aph KanR cas-
sette in bbe02; 5A18NP1 also lacks the plasmid lp56 and hence
bbq67. In electroporation studies with a shuttle vector, 5A4NP1
and 5A18NP1 yielded 10 colonies/µg DNA and 600 colonies/µg
DNA, respectively; in contrast, the parental strains 5A4 and 5A18
(which contain functional bbe02) had <1 and 14 colonies per µg
DNA. These strains thus reduce the transformation barrier while
retaining full infectivity in the mouse model (Kawabata et al.,
2004).
Utilization of pMarGent in combination with strain 5A18NP1
resulted in the first successful transposon mutagenesis of infec-
tious B. burgdorferi (Botkin et al., 2006). A small library of
33 mutants was examined for transposon insertion site by E.
coli rescue (Stewart et al., 2004), plasmid content, and infectiv-
ity in C3H/HeN mice. Mutations in the genes encoding IMP
dehydrogenase (GuaB, involved in inosine-guanine interconver-
sion) and the flagellar switch protein FlaG-1 were found to
render B. burgdorferi non-infectious, but complementation was
not attempted in these experiments. This study, although limited,
indicated the feasibility of larger scale transposon mutagenesis
studies.
ORDERED TRANSPOSON MUTANT LIBRARY
In 2007, Lin et al. (2012) began the process of accumulat-
ing a comprehensive transposon mutagenesis library utilizing
signature-tagged versions of pKGT and the B. burgdorferi B31
derivative 5A18NP1. pKGT was modified to contain 12 different
7 bp “signature tags” that could be utilized to distinguish between
co-infecting strains. This approach was based on earlier STM
studies originated by Holden and colleagues (Hensel et al., 1995),
as has been widely used for the study of bacterial-host interac-
tions and pathogenesis. Relatively few signature tags were utilized
in the construction of the B. burgdorferi library because of the
inherent difficulties in producing large numbers of mutants in
this organism. Each transformation typically yielded between 200
and 300 transformants, so several years was required to accumu-
late and characterize the number of clones estimated to yield a
near saturation library. Overall, 6325 clones were isolated, and the
insertion sites for 4479 clones were mapped by E. coli rescue and
sequencing; the insertion sites for some transformations were not
determined because of a high proportion of sibling clones. The
plasmid content of the sequence-defined clones was determined
using a novel, multiplex Luminex-based approach in which the
samples can be analyzed in a high-throughput, 96-well format
(Norris et al., 2011).
The large number of transposon mutant clones isolated pre-
cluded the use of re-cloning to assure clone purity. Although
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only well-isolated colonies were selected, it has been found that
a fair number of the preparations contain two co-isolated clones.
Colonies of B. burgdorferi are diffuse and transluscent, so this
co-isolation is most likely due to the presence of overlapping
colonies. It is recommended that the transposon mutants be re-
cloned prior to detailed analysis and examined for the presence
of other clones. The method currently in use involves PCR using
primers flanking the transposon insertion site. A “wild type” PCR
product the same size as obtained with 5A18NP1 parental strain
in addition to a larger product (consistent with the expected
transposon insertion) indicates the presence of clone(s) with
insertions at other sites.
Each transposition event represents a mini-experiment, in that
clones containing transposon insertions that significantly reduce
fitness for in vitro growth will not survive. The distribution of
transposon insertion sites thus provides a map of the genes and
other elements essential for in vitro culture or replicon main-
tenance. The map is incomplete in the case of the existing B.
burgdorferi transposon mutagenesis library, in that the library
is not saturating. However, patterns can be discerned based on
the lack of crippling mutations in groups of required genes. For
example, the only ribosomal protein gene mutation isolated was
in the last 10% of the ORF for the S21 protein, consistent with this
mutation resulting a truncated but functional product. The 22
clones recovered with mutations in one of the two 23S ribosomal
RNA genes had no obvious growth defect, indicating that cells are
functional with only a single copy of this redundant gene. Only
34% of predicted protein-encoding genes in the chromosome had
insertions, whereas 57% of predicted plasmid genes had inser-
tions, most likely because of the higher proportion of essential
genes required for in vitro culture in the chromosome. Variability
occurred in the “hit rate” of both genes and replicons, with some
genes and plasmids having as high as 23.06 (conserved hypo-
thetical gene bb0017) and 18.01 (circular plasmid cp9) unique
insertions per kb of DNA, respectively. The reason for this vari-
ability is not known, but conceivably may be related to improved
in vitro growth characteristics in some mutants. Core gene classes
that did not have debilitating mutations included those involved
in DNA synthesis, transcription, translation, protein transloca-
tion, peptidoglycan synthesis, glycolysis, and pentose phosphate
pathway, lipid interconversion, the V-type ATPase (presumably
involved in maintaining the proton gradient across the cytoplas-
mic membrane), and the ubiquitous chaperones GroE and HP70
(Lin et al., 2012). Gene mutations that were permissive for in vitro
growth includedmost of the numerous lipoprotein genes and sev-
eral genes involved in chemotaxis. Whereas an intact chemotaxis
apparatus is not required for culture, relatively few mutants were
obtained in flagellar genes. Those mutants that were obtained in
flagellar genes often produced elongated cells, indicative of defec-
tive cell division. Thus, spirochetal motility may facilitate the cell
division process.
DETECTION OF VIRULENCE DETERMINANTS IN
FUNCTIONAL GROUPS
Screening of mutants for mouse infectivity by needle inocu-
lation has been initiated using a Luminex-based STM analysis
approach (Lin et al., 2012). In a typical STM experiment, 11
mutants, each with a different signature tag, were inoculated
subcutaneously at 105 of each mutant into six C3H/HeN mice.
Groups of three mice were analyzed at 2 and 4 weeks post-
inoculation (PI), and up to five tissues (joint, heart, bladder,
inoculation site, and a distal skin site) were examined from
each mouse. In many experiments, the tissue specimens were
each examined by both direct extraction of DNA from the tis-
sue and by culture of the B. burgdorferi from the tissue followed
by DNA extraction from the culture. A semi-quantitative, high-
throughput Luminex©FlexMap™ procedure was developed for
detection of B. burgdorferi STM mutants in mammalian hosts.
The Luminex technology allows the assessment of up to 200
signals in a single well of a 96-well plate, thus providing a high-
throughput method. Five tissues per mouse (joint, heart, bladder,
inoculation site, and a distal skin site) were examined at two time
points (2 and 4 weeks) with three mice each. A relatively small
number of signature-tagged mutants were utilized in each STM
infection experiment because of the challenges of constructing B.
burgdorferi mutant libraries with multiple sequence tags, as well
as the potential of a bottleneck effect. By combining the multi-
ple mice, time points, tissues, and DNA preparation procedures,
up to 60 data points per clone were obtained in a typical STM
experiment (Lin et al., 2012). The data consisted of the Median
Fluorescence Intensity (MFI) values obtained by Luminex analy-
sis for each clone. Results obtained with representative infectious
and non-infectious clones indicated that MFI values <100 (arbi-
trary units) were consistent with low infectivity. Variability in
the numbers of organisms in individual tissue specimens occurs
because of the paucibacillary nature of infection, and averag-
ing of the multiple data points was found to yield more reliable
results.
Functional genomics and pathogenomics approaches were
applied to select mutants for the analysis of the roles of B.
burgdorferi genes in metabolism, structure, pathogenesis, and
other biological functions. The infectivity of 502 mutants in 422
genes has been tested (Lin et al., 2012), and the roles of some
of these genes in pathogenesis and biological activities are being
characterized more fully. Transposon mutations in genes associ-
ated with DNA recombination and repair, chemotaxis, motility,
transport systems, plasmid maintenance, genes involved in gene
regulation, sRNA genes, metabolic pathways, proteases, comple-
ment regulator-acquiring surface proteins (CRASPs), predicted
lipoproteins, conserved hypothetical proteins (CHPs), and hypo-
thetical proteins (HPs) of B. burgdorferi were selected for STM
screening. A representative number of mutants in intergenic
regions were also tested for infectivity to evaluate potential polar
effects, small RNA genes, and regulatory regions (Lin et al., 2012).
Some of the mutants exhibiting reduced infectivity in the STM
screen are listed inTable 2. As an example, the effects ofmutations
in 23 genes involved in DNA recombination and repair on vlsE
recombination were determined, and the results indicated that
transposon mutants in ruvA, ruvB, and mutS exhibited reduced
infectivity in mice and diminished vlsE recombination. Using this
approach and site-directed mutagenesis, RuvA, RuvB, and MutS
were the first trans-acting factors identified as necessary for vlsE
recombination and antigenic variation (Dresser et al., 2009; Lin
et al., 2009).
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Table 2 | B. burgdorferi B31 virulence determinant candidates as
indicated by STM analysisa.
Functional
categories and
gene products
Genetic
locus
STM mouse
infectivity
phenotype
Verification by
needle (N) or tick (T)
inoculation
(References)
DNA RECOMBINATION AND REPAIR
RuvA BB0023 Intermediate
infectivity
N (Lin et al., 2009);
T (Lin et al., 2009)
RuvB BB0022 Intermediate
infectivity
N (Lin et al., 2009);
T (Lin et al., 2009)
MutS BB0797 Intermediate
infectivity
N (Lin et al., 2009)
CHEMOTAXIS
CheA1 BB0567 Non-infectious T (Lin et al., 2012)
CheA2 BB0669 Non-infectious T (Lin et al., 2012)
CheB1 BB0415 Intermediate
infectivity
CheB2 BB0568 Non-infectious T (Lin et al., 2012)
CheR2 BB0414 Intermediate
infectivity
CheW2 BB0565 Non-infectious
CheW3 BB0670 Non-infectious
CheX BB0671 Non-infectious
CheY2 BB0570 Non-infectious
SulP BB0566 Non-infectious
Mcp1 BB0578 Non-infectious T (Lin et al., 2012)
(intermediate)
Mcp3 BB0597 Non-infectious
Mcp4 BB0680 Non-infectious T (Lin et al., 2012)
Mcp5 BB0681 Non-infectious T (Lin et al., 2012)
FLAGELLAR STRUCTURE AND ASSEMBLY
FliG1 BB0221 Non-infectious
FliZ BB0276 Non-infectious
FlbA BB0287 Non-infectious T (Lin et al., 2012)
FliI BB0288 Non-infectious T (Lin et al., 2012)
FliH BB0289 Non-infectious T (Lin et al., 2012)
FlaA BB0668 Non-infectious T (Lin et al., 2012)
FlgI BB0772 Non-infectious
PHOSPHOTRANSFERASE SYSTEM
ptsG BB0645 Non-infectious
FruA1 BB0408 Non-infectious
FruA2 BB0629 Variable infectivity
MalX1 BB0116 Intermediate
infectivity
MalX2 BBB29 Intermediate
infectivity
ChbB BBB06 Non-infectious
ABC TRANSPORT PROTEINS, BORRELIA EFFLUX SYSTEM (Bes),
AND OTHER TRANSPORT SYSTEMS
ProX BB0144 Intermediate
infectivity
MglA BB0318 Non-infectious
ABC transporter
ATP-binding
protein
BB0573 Non-infectious
(Continued)
Table 2 | Continued
Functional
categories and
gene products
Genetic
locus
STM mouse
infectivity
phenotype
Verification by
needle (N) or tick (T)
inoculation
(References)
OppA-2 BB0329 Intermediate
infectivity
OppA-3 BB0330 Intermediate
infectivity
OppA-4 BBB16 Variable infectivity
OppA-5 BBA34 Variable infectivity
BesA BB0141 Intermediate
infectivity
BesC BB0142 Intermediate
infectivity
LctP BB0604 Non-infectious
NhaC-1 BB0637 Non-infectious
NhaC-2 BB0638 Non-infectious
Na+/Ca+
exchange protein
BB0164 Intermediate
infectivity
GlpF BB0240 Intermediate
infectivity
GltP BB0729 Intermediate
infectivity
purine permease
P1
BBB22 Intermediate
infectivity
aTransposon mutants lacking infectivity-related plasmids (lp25, lp28-1, lp36) or
with insertions in the last 10% of the gene were excluded from this analy-
sis. Non-infectious, mean MFI <100 and <20% of tissue sites with MFI >100.
Intermediate infectivity, mean MFI between 100–500, and 20–50 percent of tis-
sue sites with MFI >100. Variable infectivity, independent transposon mutants
yielded different infectivity results. Transposon mutant STM infectivity results
that have been verified by needle or tick inoculation with individual clones are
shown with the pertinent reference(s).
Motility and chemotaxis have long been thought to be key
factors in borrelial infectivity and pathogenesis, but genetic evi-
dence for that role has been obtained only recently (Li et al., 2010;
Sze et al., 2012; Guyard et al., 2013; Sultan et al., 2013). In the
STM transposon mutant analysis, 10 of 14 mutations in chemo-
taxis genes resulted in a severe loss of infectivity, indicating that
the chemotaxis pathway is critical to infectivity (Lin et al., 2012).
The genes involved in flagellar structure and assembly are also
required for mouse infection. Some of these mutants, such as fliH,
fliI, and flbA, had reduced motility, division defects, and struc-
tural changes in the flagellar motor. The cell division, motility,
and structural defects of these mutants may all play a role in the
observed low infectivity phenotype.
Transport is another key function in pathogenesis. The phos-
phoenolpyruvate phosphotransferase system (PEP-PTS) plays an
important role in carbohydrate transportation and phospho-
rylation, also a potential role in gene regulation. STM results
consistent with non-infectivity were observed for a transposon
mutant in the gene encoding the glucose-glucoside specific IIBC
component PtsG (Table 2); reduced infectivity was observed with
mutants in the genes for the maltose specific PTS transporters
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MalX-1 andMalX-2 and the fructose-mannose transporter FruA-
1. Disparate infectivity results were obtained with two mutants in
the gene encoding the fructose-mannose specific IIB component
FruA-2, so further analysis is needed. The Chb system is thought
to play important roles in the utilization of chitobiose during
infection of ticks (Tilly et al., 2001; Rhodes et al., 2010; Sze et al.,
2013). Not surprisingly, inactivation of the genes encoding the
chitobiose-specific components ChbA and ChbC did not affect
mouse infection by needle inoculation in our system. However,
the chitobiose-specific IIBC component ChbB mutant tested
exhibited a no-infectivity phenotype (Lin et al., 2012); this finding
will require further verification and investigation. In addition, the
ABC transporter genes encoding the ATP-binding protein of the
galactose transporter MglA, ProX, and an uncharacterized ATP-
binding protein (bb0573) exhibited a low infectivity phenotype in
the STM system. The five OppA oligopeptide ABC periplasmic
binding proteins of B. burgdorferi exhibit varied infectivity phe-
notypes, but obviously have required specific binding properties.
Genes encoding the lactose permease (LctP), Na+/H+ antiporter
proteins (NhaC-1 andNhaC-2) also appear to required for mouse
infection. Mutation of Borrelia efflux system genes besC and besA,
Na+/Ca+ exchange protein (bb0164), glycerol uptake facilitator
GlpF (bb0240), glutamate transporter (bb0729), and purine per-
mease P1 (bbB22) resulted an intermediate infectivity phenotype
(Table 2).
SCREENING OF VIRULENCE GENES IN INFECTIVITY-RELATED
PLASMIDS
Lyme disease Borrelia species typically contain over 20 lin-
ear and circular plasmids. These replicons have been called
“minichromosomes” because several are required for the com-
plex life cycle of these organisms. Himar1-based transposon
mutagenesis resulted in over 2500 sequence-defined unique inser-
tion sites in the B. burgdorferi plasmids, disrupting 503 of
790 ORFs (68%); the proportion of ORFs disrupted in each
plasmid ranged from 29 (in lp5) to 91% (cp9). A high pro-
portion of borrelial plasmid genes do not have orthologs in
other organisms, so many have no predicted function. There
are also many paralogous families among the plasmid genes.
Although over 30 B. burgdorferi plasmid genes have been suc-
cessfully inactivated by site-directed mutagenesis (Rosa et al.,
2005), the availability of the transposon mutant library will
yield valuable information about these enigmatic replicons and
their genes.
To date, representative mutants in genes associated with the
infectivity-related plasmids cp26, lp25, lp28-1, lp36, and lp54
were analyzed using the STM process and Luminex-based tech-
nology (Lin et al., 2012). A summary of the results obtained for
cp26, lp36, and lp54 are displayed in Figure 2. The percentage
of positive tissue sites and mean MFI value were found to be
useful parameters in summarizing the data from many animals,
time points, tissue sites, and sampling methods, resulting in up
to 60 data points. These two criteria yielded comparable patterns
(Figure 2). The contiguous range of values sometimes does not
permit a clear “±” result, resulting in an intermediate (or indeter-
minate) infectivity category in some instances. Nevertheless, the
results obtained with mutants in these plasmids provide evidence
that a high number of genes encoded in these plasmids appear
to be required for full infectivity in mice. STM analysis is con-
sidered a screening procedure, and all results obtained by this
method need to be confirmed by single clone inoculation and
genetic complementation.
Transposon insertions were obtained in 26 of the 29 genes in
cp26. Inactivation of 11 genes appeared to render a non-infectious
phenotype based on the STM analysis, including those encoding
chitobiose transporter ChbB, the PF32 and PF49 plasmid main-
tenance proteins, CHP BBB14, GMP synthase GuaA, and OspC
(Figure 2). In addition, mutations in the genes encoding the CHP
BBB02, HP gene BBB09, GuaB (inosine-5-monophosphate dehy-
drogenase, and purine permeases PbuG1 and PbuG2) yielded
reduced STM parameter values (Figure 2) (Lin et al., 2012).
Mutants in the genes encoding OspC, GuaA, GuaB, PbuG1,
and PbuG2 had all been identified as virulence determinants
previously (Byram et al., 2004; Grimm et al., 2004; Pal et al.,
2004; Stewart et al., 2006; Tilly et al., 2006, 2009; Jewett et al.,
2007a).
Of the 60 annotated genes in lp36, 38 protein-encoding genes
have been disrupted. Transposon insertions were also found in
one small RNA gene and two intergenic spacers. A total of 41
unique mutants have been examined for their infectivity in STM
system (Figure 2). Consistent with previously published report
by Jewett et al. (2007b), our result indicates that inactivation of
the gene encoding adenine deaminase AdeC resulted in reduced
mouse infection. Disruption of the BBK32 fibronectin-binding
protein gene did not have an apparent effect on infectivity. BBK32
is involved in vascular endothelium adherence and dissemination,
but is not absolutely required for infection (Li et al., 2006; Seshu
et al., 2006; Norman et al., 2008; Moriarty et al., 2012); it is pos-
sible that the high infectious dose (105) used for each mutant in
the STM analysis was sufficient to establish disseminated infec-
tion. Mutations in a region encompassing bbk02.1 to bbk07 (a
poorly defined region in which some of the genes are no longer
annotated) resulted in decreased infectivity. Mutations in several
other CHP genes appear to result in reduced infectivity, includ-
ing those in bbk15, and putative lipoprotein genes bbk13, bbk36,
bbk37, and bbk45 through bbk50 (Figure 2) (Lin et al., 2012). In
vivo expression technology (IVET) studies by Ellis et al. (2013)
indicated that bbk46 is highly expressed during mouse infection,
and further analysis showed that a bbk46 mutant was defective in
persistent infection of mice.
Linear plasmid lp54 is one of the most highly conserved ele-
ments in the Borrelia genome. A total of 75 protein-encoding
genes are encoded on lp54, and some of them are differentially
expressed in tick vector and mammalian hosts. Most proteins
encoded on lp54 do not have homologs in other organisms and
are of unknown function (Casjens et al., 2000; Jewett et al.,
2007a). Transposon mutants were obtained in 58 genes on lp54,
and a high proportion of these mutants had decreased infectiv-
ity (Figure 2). Most of these are Borrelia species-specific proteins
with unknown functions and several are B. burgdorferi-specific
proteins. Transposon insertions in BBA03 (outer surface pro-
tein), BBA14 (OrfD paralog), BBA21 (PF49), BBA24 (DbpA),
BBA30 (CHP), BBA31 (CHP), BBA35 (HP), BBA40 (HP), BBA43
(CHP), BBA44 (CHP), BBA55 (CHP), BBA57 (CHP), and BBA59
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FIGURE 2 | Mouse infectivity of transposon mutants in plasmid-encoded
genes, as determined by Luminex-based STM analysis. Results obtained
for genes in plasmids cp26, lp36, and lp54 are shown. For each mutant, the
data represent the percent of positive tissue sites (MFI >100; blue bars) and
mean MFI value (red bars) for 30–60 data points. Only clones that have all
plasmids known to be required for mouse infection (cp26, lp25, lp28–1, lp36,
and lp54) were analyzed. The gene designation, insertion ratio (bp from 5′
end to insertion/total bp), and description are provided. Abbreviations: HP,
hypothetical protein; CHP, conserved hypothetical protein; para., paralog;
pseudo., pseudogene; put. LP, putative lipoprotein; t’ase, transposase.
(CHP) resulted in a non-infectious phenotype by STM analysis.
Additional mutants exhibited reduced STM analysis parame-
ters, and may also have attenuated phenotypes. Disparate results
were obtained for bba04, with two clones having high and low
infectivity phenotypes (Figure 2) (Lin et al., 2012). Bestor et al.
(2012) determined previously that a bba03 deletion mutant had
a competitive disadvantage in tick-mediated infection of mice in
comparison to the wild type parental strain; a deletion mutant
lacking bba01-bba07 was further attenuated, indicating that other
genes in this region may be required for full infectivity in mice.
In other studies, site-directed disruption of the decorin bind-
ing protein DbpA was found to reduce mouse infectivity by
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needle inoculation but not by tick-mediated infection (Hagman
et al., 2000); the transposon mutant results are consistent with
the prior needle inoculation findings. Mutation in gene of ospB
had little apparent effect on mouse infection, although this sur-
face lipoprotein expressed predominantly in the tick infection
and play the important role in tick midgut colonization. BBA64
is a member of the P35 paralogous protein family, and previ-
ous studies indicated that BBA64 is required for tick transmission
(Gilmore et al., 2010), but mutants in this gene had only minor
effects on infection by needle inoculation (Maruskova and Seshu,
2008; Maruskova et al., 2008). The STM analysis was consistent
with the latter result, in that the available bba64 mutant (which
had a transposon insertion in last 16% of reading frame) was
fully infectious (Figure 2); in this case, however, it is possible
that the mutant expresses a truncated but functional protein.
Further studies with BBA64 immunization indicate that antibod-
ies against this protein do not protect against needle or tick infec-
tion (Brandt et al., 2014). STM analysis indicated that mutation of
lp54-encoded protein Oms28 (bba74) resulted in decreased infec-
tivity (Lin et al., 2012), but these results are not consistent with
prior studies with B31 A3, which apparently expresses a truncated
BBA74 product (Mulay et al., 2009).
BptA, PncA, and Bbe31 encoded on lp25 had been identified
as virulence determinants previously (Purser et al., 2003; Revel
et al., 2005; Strother et al., 2005; Zhang et al., 2012). The trans-
poson mutant library contains insertions in the genes encoding
BptA and PncA, and these mutants exhibited reduced or non-
infectivity as reported previously. In addition, mutations in genes
of bbe04.1, bbe09, bbe18, bbe19, bbe24, and bbe29.1 substantially
reduced infectivity, and intermediate infectivity was observed in
mutants in genes of bbe07 and bbe18 (Lin et al., 2012).
In the STM studies, low infectivity was observed among lp28-
1 mutants of genes encoding BBF03, BBF05, BBF10, BBF18, and
BBF25. Mutation of genes of BBF04, BBF07, BBF08, BBF12,
BBF19 appear to cause reduce infectivity. Interestingly, transpo-
son insertions in intergenic spacers between bbf25-26 and bbf28-
29 causes severe defect in spirochete infectivity (Lin et al., 2012).
The vls locus involved in VlsE antigenic variation and immune
evasion is located at one end of lp28-1 (Zhang et al., 1997). Only
one transposon insertion was obtained in the vls silent cassettes,
and none were obtained in the vlsE expression site (Lin et al.,
2012). The silent cassette mutant was infectious, indicating that
interruption of the silent cassette region is not sufficient to inhibit
the vlsE recombination process.
Tn-SEQ
Transposon insertion site sequencing approaches such as Tn-seq
is a powerful genetic screening technique in which high-
throughput sequencing is used as a detection method in transpo-
son mutagenesis screens to identify the contribution of individual
genes to bacterial fitness under specific growth conditions (van
Opijnen and Camilli, 2013). A library of transposon mutants
(input pool) can be utilized to infect animals or subjected to
in vitro selection conditions, and the resulting organisms (out-
put pool) collected. Amplification of the transposon insertion
site region and massively parallel sequencing provides a high-
throughput comparison of the input pool and output pool. In
comparison with STM approaches, Tn-seq has several advan-
tages (Table 3), including the ability to examine an entire library
in one set of replicate experiments without prior characteriza-
tion of the insertion sites. For Borrelia studies, a disadvantage
is that the plasmid content of each clone is not known, so
the low infectivity of a particular mutant may be due to con-
comitant plasmid loss. Thus, presence of more than one clone
with a mutation in a particular gene in the input pool and the
underrepresentation of those clones in the output pool may be
necessary to establish the gene product as a potential virulence
determinant.
In 2013, Troy et al. adapted Tn-seq for use in studies of B.
burgdorferi using the STM transposon library (Troy et al., 2013).
In a Tn-seq experiment, the transposon library is subjected to
growth under a test condition. Genomic DNA is then isolated
from the B. burgdorferi population before and after selection.
The DNA is fragmented and cytosine tails (C-tails) are added
using terminal deoxynucleotidyl transferase. The addition of a
C-tail allows for the amplification of the transposon-genomic
Table 3 | Advantages and disadvantages of ordered library,
signature-tagged mutagenesis (STM) and Tn-seq approaches.
Approach Advantages Disadvantages
STM analysis Does not require availability
of high-throughput
sequencing
Requires sequence analysis
of the Tn insertion points of
individual clones of interest
either before (ordered
library) or after STM
screening
Tn mutant clones available
for further analysis after
STM screening
Relatively low throughput
method that requires
multiple animal
experiments for infectivity
screening
Relatively small number of
clones used per experiment
decreases possibility of
bottleneck effects
Potential
cross-contamination during
clone isolation can
complicate interpretation
Tn-seq Capacity to screen an entire
library in a single infectivity
experiment
Lack of plasmid content
information; low infectivity
may be related to plasmid
loss
Does not require isolation
and characterization of
individual Tn mutant clones
Tn mutants of interest
would have to be re-isolated
for further study (if not from
an ordered library)
Easier application to in vitro
screening methods (e.g.,
metabolic, adherence, or
cell co-culture experiments)
Possible bottleneck effects
(non-uniform recovery of
organisms) may necessitate
use of large numbers of
animals or cultures
Relatively high minimum
analysis cost
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DNA junction using primers specific to the ColE1 site on the
end of the transposon and the C-tail. The relative abundance of
each mutant is determined by sequencing the chromosomal DNA
flanking the transposon en masse using a primer that anneals to
the end of the transposon. In this way, the exact location of every
transposon insertion present in the library is revealed. The fre-
quency of the insertion sequence in the library corresponds to
the frequency of the transposon mutant containing that insertion
in the original bacterial populations. The fitness of each inser-
tion mutant in the test condition is determined by comparing
the relative frequency of each mutant before and after growth
under the selective pressure. Sequences that decrease in frequency
in the library after selection have insertions in genes contribut-
ing to bacterial growth in the test condition. The quantitative
nature of the high-throughput sequencing enables the discovery
of unknown growth determinants including the differentiation
of factors with partial phenotypes and/or those acting in redun-
dant pathways. Furthermore, due to the non-specific nature of the
genome library preparation, this Tn-seq technique can be used
with any transposon as long as the sequence of the 3′ end of the
transposon is known.
Tn-seq is particularly amenable to in vitro screens as unlike
STM experiments that are limited to a small subset of mutants
in each experiment, the entire transposon library can be tested
in a single competition assay. Tn-seq has also been used to
screen in vivo fitness. However, a potential complication of ani-
mal screens is a population bottleneck at the site of infection
that results in the stochastic loss of a significant portion of the
injected B. burgdorferi by 3 days post-infection. If all transpo-
son mutants containing a particular insertion are lost at the
inoculation site due to the bottleneck rather than decreased
fitness, the disrupted gene may be misidentified as contribut-
ing to bacterial survival during infection. However, experiments
by Troy et al. have demonstrated that the effects of this bot-
tleneck can be circumvented, at least in part, by combining
results from the B. burgdorferi populations recovered from mul-
tiple mice infected with the same inoculum (Troy et al., 2013).
Part of the bottleneck effect is due to innate immune mecha-
nisms (resulting in a non-specific reduction of the inoculated
population), as demonstrated by the reduced magnitude of
the bottleneck in MyD88−/− mice in comparison with wild
type mice.
CONCLUSIONS
Results obtained to date with B. burgdorferi transposon mutants
indicate that a high proportion of genes are required for mouse
infection. The assessment of multiple tissue sites at two differ-
ent time points using Luminex FlexMap technology provides a
robust data set. Tn-seq has multiple advantages and is expected to
greatly accelerate the application of transposon mutant libraries
to studies of infectivity and other biological processes. Both STM
and Tn-seq are considered screening methods, so the results
must be confirmed by studies with isolated transposon mutants
(or independently derived mutants) and genetic complemention.
In addition, polar effects on downstream genes should be ver-
ified for observed reduced infectivity phenotype. All mutants
should be re-cloned prior to more thorough studies due to the
potential occurrence of co-isolation of two or more clones in a
single colony. Finally, cross-complementation may occur between
clones in the transposon library. We believe that the continued
analysis of the mutant library will lead to a more comprehensive
delineation of the virulence determinants of B. burgdorferi and
will improve our understanding of the novel pathogenic and bio-
logic properties of Lyme Borrelia organisms and other invasive,
non-toxigenic, persistent pathogens.
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